Intellectual Property

Through the creation, registration, and administration of vital proprietary assets, such as manufacturing, know-how, products, methods, and expertise, Sanostem has maintained a competitive edge. The goal of Sanostem’s internal patent department is to identify and safeguard the company’s intellectual property.

The patent department implements a thorough program to stop rivals from copying, avoiding, or reverse-engineering its most valuable assets. Trade secrets and patents are two facets of the company’s intellectual property program. Seven approved “keystone patents” and fourteen published and pending applications in the USPTO make up the published component of Sanostem’s intellectual property portfolio.

Intellectual Property

Through the creation, registration, and administration of vital proprietary assets, such as manufacturing, know-how, products, methods, and expertise, SanoStem has maintained a competitive edge. The goal of SanoStem’s internal patent department is to identify and safeguard the Company’s intellectual property.

The patent department implements a thorough program to stop rivals from copying, avoiding, or reverse-engineering its most valuable assets. Trade secrets and patents are two facets of the Company’s intellectual property program. Seven approved “keystone patents” and fourteen published and pending applications in the USPTO make up the published component of SanoStem’s intellectual property portfolio.

Issued Patents:

US 8,105,380 for Cellular Scaffold, Issued January 31, 2012
Cellular Scaffold, Issued April 29, 2014, US 8,709,081
Issued April 16, 2013, US 8,420,394 for Culturing Ectodermal Cells Under Reduced Oxygen Tension. A continuing application for the treatment of CNS illnesses is part of the patent family.
US 8,642,286 for Neuripotent Cell Identification Techniques, Published February 4, 2014
On November 27, 2012, US 8,318,485 was issued for the use of stem cell therapy to treat diabetic retinopathy and optic neuropathy.
US 8,790,638 for Stem Cell Compositions and Stem Cell Factors and Procedures for Their Utilization and Production, Published July 29, 2014
Transgenic Therapeutic Stem Cells and Procedures for Their Utilization and Production, US 9,080,184, July 14, 2015

Published U.S. Patent Applications:

Sandwiched Biodegradable Microneedle, US 2016/0287668
Combination Therapy for the Treatment of Hair Loss (US 2017/0252373)
US 2012/0141433 for Topical and Other Therapeutic Applications of Vaporized Stem Cell Derivatives
Methods for Using Stem Cells and Stem Cell Factors in the Treatment of Skin Conditions (US 2012/0201786)
US 2016/0324898 for Alzheimer's Disease Treatment Compositions and Techniques
Differentiation of RPE Progenitors into Neuron-Like Cells (US 2016/0222349)
US 2017/0027990 for Using Ischemic Tolerant Allogeneic Mesenchymal Bone Marrow Cells to Treat Mental States in Patients Following Ischemic Brain Injury
US 2016/0143950 for Stem Cells and Stem Cell Factors to Stop Alzheimer's Disease from Getting Worse
US 2014/0286910 for Stem Cells and Techniques Using Environmental Elements to Increase the Proliferation and Plasticity of Stem Cells
Stem Cell Therapy for the Treatment of Disorders of the Central Nervous System (US 2013/0177537)
US 2016/0220611 for Acute Coronary Syndrome Treatment Using Ischemic Tolerant Cells
US Chimeric Transplant 2008/0292598
Energy-Assisted Stem Cell Extract, US 2007/0231307
Catheter with Body Wall Separator, US 2013/0085468

Intellectual Property